Long Term Care Journal
Thursday, March 29, 2018
FDA expands approval of Blincyto for treatment of a type of leukemia in patients who have a certain risk factor for relapse - FDA Press Releases
FDA expands approval of Blincyto for treatment of a type of leukemia in patients who have a certain risk factor for relapse
from Food and Drug Administration--Press Releases https://ift.tt/2GS9kRv
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment